All-cause mortality in moderate and severe COVID-19 patients with myocardial injury receiving versus not receiving azvudine: a propensity score-matched analysis

Omicron is currently the dominant strain of severe acute respiratory syndrome coronavirus 2, but little is known about the characteristics and management of omicron related myocardial injury, particularly the potential benefit of the antiviral agent azvudine. METHODS: Patients with confirmed and sus...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ru, Guo, Yi, Deng, Shan, Wang, Jian, Gao, Meng, Han, Hongli, Wang, Lin, Jiang, Hongwei, Huang, Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364645/
https://www.ncbi.nlm.nih.gov/pubmed/37539021
http://dx.doi.org/10.1097/CP9.0000000000000049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364645/
https://www.ncbi.nlm.nih.gov/pubmed/37539021
http://dx.doi.org/10.1097/CP9.0000000000000049

Ejemplares similares